TetraLogic rises 22% to $14.00 Strength in shares of Tetralogic (TLOG) has been at least partially attributed to the circulation of an article originally published Jan. 6 by The Cornell Chronicle regarding a study in which researchers destroyed metastasizing cancer cells by attaching a cancer-killer protein to white blood cells. The study process used TNF-related apoptosis-inducing ligand, or TRAIL, coated leukocytes, which is an area that TetraLogic is exploring in its research. The company also posted a new presentation to its website with technical information on its development pipeline. Reference Link
News For TLOG From The Last 14 Days
Check below for free stories on TLOG the last two weeks.